Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phytic acid is a naturally occurring compound found primarily in plant seeds, grains, legumes, and nuts. Chemically known as myo-inositol hexakisphosphate (IP6 or InsP6), it serves as the principal storage form of phosphorus in many plant tissues[4][5]. At physiological pH, it exists mainly as the phytate anion. Phytic acid is notable for its strong chelating properties; it binds essential minerals such as calcium, iron, and zinc and can inhibit their absorption in the small intestine[3][4][5]. This has led to its classification as an "antinutrient," though real-world evidence suggests that mineral deficiencies due to dietary phytic acid are rare with balanced diets[3][5]. Beyond its antinutritional effects, phytic acid exhibits several bioactive properties including antioxidant activity and potential roles in disease prevention. It has been investigated for use as an iron chelator and antineoplastic agent (anti-cancer), with additional research suggesting benefits such as anti-inflammatory effects and inhibition of pathological calcification (e.g., vascular calcification)[1][2][5]. Phytic acid is under clinical investigation for preventing progression of cardiovascular calcifications[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phytic acid.